Product Description
The global remote patient monitoring market was valued at nearly $5.1 billion in 2024. This is expected to increase over the forecast period at a CAGR of 10.3% to reach over $10 billion.
The full report suite on the global market for remote patient monitoring (RPM) includes disease conditions management and cardiac implantable electronic devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL REMOTE PATIENT MONITORING MARKET TRENDS
As of 2022, it is estimated that approximately 10% of the global population is over the age of 65, with this proportion increasing every year. A growing elderly population will require more access to healthcare in the future, thereby driving the growth of the RPM market.
Global Remote Patient Monitoring Market Share Insights
- Medtronic. was the leading competitor in the RPM market for 2024. Medtronic’s ongoing partnership with the Veterans Health Administration’s (VHA’s) Care Coordination and Home Telehealth (CCHT) program following Bosch Healthcare’s exit has fortified its position as the market leader within the total RPM market.
- Philips Healthcare was the second-leading competitor in the RPM market in 2024. The company offers remote monitoring to patients with its eCareCompanion™ platform, which connects via cellular or Wi-Fi networks to deliver cloud-based telehealth services.
- Honeywell Life Sciences is the third-leading competitor in the RPM market for 2024. The company’s Genesis Touch™ v2 is an RPM device with 3G, 4G and Wi-Fi connectivity that collects health metrics and transmits this data to its LifeStream™ Management Suite. Honeywell also offers tailored, symptom-specific management with its Genesis DM™, which features voice-enabled, disease-specific symptom management (DSSM) questions and tools, as well as LifeStream™ Management Suite
GLOBAL REMOTE PATIENT MONITORING EQUIPMENT MARKET SEGMENTATION SUMMARY
- Disease Conditions Management Market
- Cardiac Implantable Electronic Device Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
